CORNEAT VISION, LTD. recalls CorNeat EverPatch

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

On August 18, 2025, CorNeat Vision, Ltd. issued a "Urgent: Medical Device Recall" Notification to affected consignees via E-Mail. CorNeat ask consignees to take the following actions: 1. Review inventory, Quarantine and Discontinue use of All Lots of the CorNeat EverPatch and/or EverPatch+. 2. Please discard any unused product. 3. Eyecare providers should continue to monitor patients who have had CorNeat EverPatch and/or EverPatch+ implanted at the follow-up frequency necessary to detect signs of wound dehiscence or conjunctival thinning/erosion. 4. Patients should be instructed to seek prompt follow-up if they experience any signs or symptoms consistent with this complication. 5. This notice needs to be passed on to all those within your organization or to any organization where the product has been transferred. 6. Please fill in the MEDICAL DEVICE RECALL RETURN RESPONSE form at www.corneat.com/everpatch-recall or fill in the attached form and forward to CorNeat Vision by email to complaints@corneat.com .

• FDA enforcement recordOfficial FDA database entry for Z-0039-2026
• FDA 510(k) clearance · K223074The device's official FDA premarket clearance record
• FDA device classification · QWUOfficial FDA classification for this device type
• CFR regulation · 21 CFR 886.3130The federal regulation governing this device
• FDA recall announcementSearch FDA.gov for the official press announcement
• Find CORNEAT VISION, LTD.Search for the manufacturer's official notice
• News coverageRecent reporting on this recall and manufacturer
• openFDA data recordThe raw JSON record this page is built from

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.